Nonetheless, the in vivo relevance of PDI sulfenylation in thrombosis was determined with a model of dyslipidemia, where wildtype C57Bl/6J mice were infused intravenously with oxLDL [72,113,114]. The gene discussed is P4HB; the disease is metabolic syndrome.